GILD

127.23

2.36% 2.93

시간 외 거래: 127.03 -0.20 -0.16%

길리어드 사이언스 (GILD)

개요 뉴스 가격 이력 옵션 체인 Financials GILD 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$124.30

열려 있는:

$125.22

하루 거래량:

9.09M

Relative Volume:

1.41

시가총액:

$157.96B

수익:

$29.79B

순이익/손실:

$9.22B

주가수익비율:

17.31

EPS:

7.3494

순현금흐름:

$10.23B

1주 성능:

+1.38%

1개월 성능:

-1.81%

6개월 성능:

+7.11%

1년 성능:

+14.80%

1일 변동 폭

$124.14

$128.18

1주일 범위

$121.39

$128.18

52주 변동 폭

$104.46

$157.29

길리어드 사이언스 Stock (GILD) Company Profile

명칭

Gilead Sciences Inc

부문

Healthcare (1107)

산업

Drug Manufacturers - General (20)

전화

(650) 574-3000

주소

333 LAKESIDE DR, FOSTER CITY, CA

직원

17,000

트위터

@GileadSciences

다음 수익 날짜

2026-08-06

최신 SEC 제출 서류

GILD's Discussions on Twitter

Compare GILD vs LLY, JNJ, ABBV, NVS, MRK

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
GILD Gilead Sciences Inc	127.23	154.33B	29.79B	9.22B	10.23B	7.3494
LLY Lilly Eli Co	1,122.50	1.01T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	235.18	567.28B	96.36B	21.04B	17.80B	8.6488
ABBV Abbvie Inc	222.47	391.50B	62.82B	3.60B	19.98B	2.0274
NVS Novartis Ag Adr	150.93	289.19B	54.66B	13.58B	16.05B	7.0171
MRK Merck Co Inc	115.17	283.78B	65.51B	8.93B	14.12B	3.5532

길리어드 사이언스 Stock (GILD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-10	개시	Jefferies	Buy
2026-02-20	개시	Barclays	Equal Weight
2026-02-11	재확인	Needham	Buy
2026-01-07	재개	UBS	Buy
2025-11-24	재개	Truist	Buy
2025-11-13	개시	Scotiabank	Sector Outperform
2025-08-19	업그레이드	Daiwa Securities	Neutral → Outperform
2025-08-08	업그레이드	Truist	Hold → Buy
2025-07-25	업그레이드	Needham	Hold → Buy
2025-04-22	재개	Cantor Fitzgerald	Overweight
2025-03-04	재확인	Oppenheimer	Outperform
2025-02-18	업그레이드	Deutsche Bank	Hold → Buy
2025-02-13	업그레이드	DZ Bank	Hold → Buy
2025-01-10	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-11-14	개시	Citigroup	Buy
2024-11-08	다운그레이드	Maxim Group	Buy → Hold
2024-10-21	업그레이드	Leerink Partners	Market Perform → Outperform
2024-10-17	개시	Bernstein	Outperform
2024-10-07	업그레이드	Wells Fargo	Equal Weight → Overweight
2024-07-08	업그레이드	Raymond James	Mkt Perform → Outperform
2024-05-01	재확인	Maxim Group	Buy
2024-04-24	업그레이드	HSBC Securities	Reduce → Hold
2024-02-22	다운그레이드	Truist	Buy → Hold
2023-11-09	개시	Deutsche Bank	Hold
2023-09-08	업그레이드	BofA Securities	Neutral → Buy
2023-09-06	개시	HSBC Securities	Reduce
2023-07-24	재확인	Barclays	Equal Weight
2023-05-16	업그레이드	BMO Capital Markets	Market Perform → Outperform
2023-04-28	재개	Piper Sandler	Overweight
2023-01-03	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-12-13	재개	BofA Securities	Neutral
2022-12-09	다운그레이드	DZ Bank	Buy → Hold
2022-10-31	업그레이드	Barclays	Underweight → Equal Weight
2022-10-28	재확인	BMO Capital Markets	Market Perform
2022-10-28	재확인	Cowen	Outperform
2022-10-28	재확인	JP Morgan	Overweight
2022-10-28	재확인	Jefferies	Buy
2022-10-28	업그레이드	Piper Sandler	Neutral → Overweight
2022-10-28	재확인	RBC Capital Mkts	Outperform
2022-10-28	업그레이드	Truist	Hold → Buy
2022-10-28	재확인	Wells Fargo	Equal Weight
2022-10-04	업그레이드	JP Morgan	Neutral → Overweight
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-05-23	개시	SVB Leerink	Mkt Perform
2022-02-28	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2022-02-02	재확인	BMO Capital Markets	Outperform
2022-02-02	재확인	BofA Securities	Neutral
2022-02-02	재확인	RBC Capital Mkts	Outperform
2022-02-02	재확인	Truist	Hold
2022-02-02	재확인	Wells Fargo	Equal Weight
2022-01-28	업그레이드	Argus	Hold → Buy
2022-01-06	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-12-09	재개	Wells Fargo	Equal Weight
2021-12-06	개시	Goldman	Neutral
2021-11-19	업그레이드	BMO Capital Markets	Market Perform → Outperform
2021-11-19	재개	Piper Sandler	Neutral
2021-10-20	재개	Cowen	Outperform
2021-07-30	재확인	BMO Capital Markets	Market Perform
2021-07-30	재확인	RBC Capital Mkts	Outperform
2021-04-01	업그레이드	Bernstein	Mkt Perform → Outperform
2021-03-30	업그레이드	Redburn	Neutral → Buy
2021-01-19	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-01-04	업그레이드	Guggenheim	Neutral → Buy
2020-11-03	재개	Morgan Stanley	Equal-Weight
2020-10-28	개시	UBS	Neutral
2020-09-30	재개	Jefferies	Buy
2020-09-15	업그레이드	Maxim Group	Hold → Buy
2020-07-31	재확인	Credit Suisse	Neutral
2020-07-31	재확인	Morgan Stanley	Equal-Weight
2020-07-31	재확인	Piper Sandler	Overweight
2020-07-31	재확인	RBC Capital Mkts	Outperform
2020-07-31	재확인	SunTrust	Hold
2020-07-31	재확인	Wells Fargo	Equal Weight
2020-07-20	업그레이드	Credit Suisse	Underperform → Neutral
2020-06-03	업그레이드	SVB Leerink	Mkt Perform → Outperform
2020-05-26	업그레이드	SunTrust	Sell → Hold
2020-05-01	다운그레이드	JP Morgan	Overweight → Neutral
2020-05-01	다운그레이드	Raymond James	Outperform → Mkt Perform
2020-05-01	다운그레이드	SunTrust	Hold → Sell
2020-04-27	다운그레이드	UBS	Buy → Neutral
2020-04-20	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2020-04-20	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-04-17	다운그레이드	CFRA	Hold → Sell

모두보기

길리어드 사이언스 주식(GILD)의 최신 뉴스

Jun 15, 2026

Gilead Sciences (GILD) Seeks FDA Approval for Weekly HIV Prevention Pill - GuruFocus

Jun 15, 2026

GILD Receives FDA Acceptance for Yeztugo as HIV Preventative - GuruFocus

Jun 15, 2026

Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Jun 15, 2026

FDA accepts Gilead application for once-weekly oral HIV prevention pill - Investing.com Canada

Jun 15, 2026

Director sale notice: GILD (NASDAQ: GILD) files Form 144 for 9,000 shares - Stock Titan

Jun 15, 2026

U.S. FDA Accepts Gilead’s Application for Investigational Once-Weekly Oral Yeztugo, Potentially the First Long-Acting Pill for HIV Prevention - Yahoo Finance Singapore

Jun 15, 2026

Morgan Stanley files Rule 144 for GILD common shares (GILD) - Stock Titan

Jun 15, 2026

Regulatory Milestone Boosts Gilead’s Presence in Liver Disease Care - Insider Monkey

Jun 15, 2026

Former Gilead COO Asks Judge to Nix `Rape’ in Woman’s Harassment Trial - MyNewsLA.com

Jun 15, 2026

Gilead Sciences Patent Application Challenged Over Potential Impact on ARIPO Contracting States - pan african visions

Jun 15, 2026

Panagora Asset Management Inc. Sells 321,348 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 15, 2026

Public Employees Retirement Association of Colorado Has $111.55 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 15, 2026

Resources Management Corp CT ADV Lowers Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 15, 2026

Arax Advisory Partners Has $3.60 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 15, 2026

Atlas Capital Advisors Inc. Takes $1.01 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 15, 2026

Jun 14, 2026

Gilead Sciences, Inc. $GILD Shares Acquired by Healthcare of Ontario Pension Plan Trust Fund - MarketBeat

Jun 14, 2026

177,100 Shares in Gilead Sciences, Inc. $GILD Purchased by Adams Diversified Equity Fund Inc. - MarketBeat

Jun 14, 2026

Jun 13, 2026

Gilead Sciences (GILD) Reports Positive Phase 3 IDEAL Results for Livdelzi in PBC - Insider Monkey

Jun 13, 2026

Voya Global High Dividend Low Volatility Portfolio's Gilead Sciences Inc(GILD) Holding History - GuruFocus

Jun 13, 2026

Victory Capital Management Inc. Sells 109,808 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 13, 2026

Gilead Sciences, Inc. $GILD Shares Bought by State Street Corp - MarketBeat

Jun 13, 2026

Gilead (GILD) Supports Faster South Africa Access to Lenacapavir - Insider Monkey

Jun 13, 2026

Martingale Asset Management L P Acquires 21,153 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 13, 2026

Rhenman & Partners Asset Management AB Buys 46,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 13, 2026

Titan Investment Solutions Ltd Invests $6.20 Million in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 13, 2026

Trillium Asset Management LLC Decreases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 13, 2026

Macquarie Group Ltd. Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 13, 2026

Gilead Sciences, Inc. $GILD Shares Purchased by Banco Santander S.A. - MarketBeat

Jun 13, 2026

Castleark Management LLC Boosts Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 13, 2026

4,220,501 Shares in Gilead Sciences, Inc. $GILD Bought by Boston Partners - MarketBeat

Jun 13, 2026

Jun 12, 2026

Gross profit of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView

Jun 12, 2026

Enterprise value of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView

Jun 12, 2026

Net income before discontinued operations of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView

Jun 12, 2026

Long term debt to total assets ratio of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView

Jun 12, 2026

Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh Dividends – BCBA:GILD.CI - TradingView

Jun 12, 2026

Long term debt to total equity ratio of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView

Jun 12, 2026

GILD Donates Antiviral Therapy to Support Ebola Response in Ugan - GuruFocus

Jun 12, 2026

Gilead donates remdesivir to Uganda for Ebola outbreak response - Investing.com

Jun 12, 2026

Gilead donates remdesivir to Uganda for Ebola outbreak response By Investing.com - Investing.com Canada

Jun 12, 2026

Gilead Mobilizes Rapid Donation of Remdesivir to Support Ebola Response, Building on Decade-Long Commitment to Outbreak Relief - Business Wire

Jun 12, 2026

UniSuper Management Pty Ltd Sells 124,258 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Vaughan David Investments LLC IL Invests $33.80 Million in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Xponance LLC Has $29.15 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

FY2026 EPS Forecast for Gilead Sciences Reduced by Analyst - MarketBeat

Jun 12, 2026

Gilead Sciences, Inc. $GILD Shares Acquired by Sector Gamma AS - MarketBeat

Jun 12, 2026

Swiss National Bank Has $417.34 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Te Ahumairangi Investment Management Ltd Sells 8,180 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Meiji Yasuda America Inc Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Nuveen LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 12, 2026

Gilead Sciences, Inc. $GILD Shares Purchased by Great Lakes Advisors LLC - MarketBeat

Jun 12, 2026

Gilead Sciences, Inc. $GILD Shares Acquired by DJE Kapital AG - MarketBeat

Jun 12, 2026